Skip to content
The Nexus
DossierENTITY

oncologists

Coverage of oncologists in the Nexus archive.

Earliest in view: Jun 4 · 20:18 UTCMost recent: Jun 4 · 20:18 UTC
Co-mentioned in this coverage
Revolution Medicinesorganization1daraxonrasibtopic1biotech stockstopic1pancreatic cancertopic1The Readout LOUDorganization1
Recent coverage
  • HEALTHJun 4 · 20:18 UTCSTAT NEWS
    What RevMed’s pancreatic cancer drug meant for one patient

    Revolution Medicines' pancreatic cancer drug, daraxonrasib, received a standing ovation from oncologists during a data presentation. The article also addresses the poor performance of biotech stocks this week and discusses other topics on 'The Readout LOUD' podcast.

oncologists · Dossier · The Nexus